raloxifene hydrochloride has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamdade, VS; Kumar, P; Lahkar, M; Mundhe, NA; Tadla, V | 1 |
| Akamatsu, K; Kurose, H; Kusakabe, M; Li, ZL; Morimoto, J; Ohmichi, M; Otsuki, Y; Shibata, E; Shibata, MA | 1 |
2 other study(ies) available for raloxifene hydrochloride and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Cisplatin; Drug Synergism; Female; Inflammation; Kidney Diseases; Mammary Neoplasms, Animal; NF-kappa B; Raloxifene Hydrochloride; Rats; Rats, Wistar; Signal Transduction | 2016 |
Raloxifene inhibits tumor growth and lymph node metastasis in a xenograft model of metastatic mammary cancer.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Estrogen Receptor alpha; Female; Humans; Lymphatic Metastasis; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Factors | 2010 |